The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy

Glioblastoma (GB) is the most aggressive form of brain cancer in adults, characterized by poor survival rates and lack of effective therapies. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression post-transcriptionally through specific pairing with target messenger RNAs (mRNAs...

Full description

Bibliographic Details
Main Authors: Natalia Simionescu, Radu Zonda, Anca Roxana Petrovici, Adriana Georgescu
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/7/988
_version_ 1797528274904023040
author Natalia Simionescu
Radu Zonda
Anca Roxana Petrovici
Adriana Georgescu
author_facet Natalia Simionescu
Radu Zonda
Anca Roxana Petrovici
Adriana Georgescu
author_sort Natalia Simionescu
collection DOAJ
description Glioblastoma (GB) is the most aggressive form of brain cancer in adults, characterized by poor survival rates and lack of effective therapies. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression post-transcriptionally through specific pairing with target messenger RNAs (mRNAs). Extracellular vesicles (EVs), a heterogeneous group of cell-derived vesicles, transport miRNAs, mRNAs and intracellular proteins, and have been shown to promote horizontal malignancy into adjacent tissue, as well as resistance to conventional therapies. Furthermore, GB-derived EVs have distinct miRNA contents and are able to penetrate the blood–brain barrier. Numerous studies have attempted to identify EV-associated miRNA biomarkers in serum/plasma and cerebrospinal fluid, but their collective findings fail to identify reliable biomarkers that can be applied in clinical settings. However, EVs carrying specific miRNAs or miRNA inhibitors have great potential as therapeutic nanotools in GB, and several studies have investigated this possibility on in vitro and in vivo models. In this review, we discuss the role of EVs and their miRNA content in GB progression and resistance to therapy, with emphasis on their potential as diagnostic, prognostic and disease monitoring biomarkers and as nanocarriers for gene therapy.
first_indexed 2024-03-10T09:56:53Z
format Article
id doaj.art-91e2cffa35ff4291a69acb869dcb26ad
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T09:56:53Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-91e2cffa35ff4291a69acb869dcb26ad2023-11-22T02:18:28ZengMDPI AGPharmaceutics1999-49232021-06-0113798810.3390/pharmaceutics13070988The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene TherapyNatalia Simionescu0Radu Zonda1Anca Roxana Petrovici2Adriana Georgescu3Center of Advanced Research in Bionanoconjugates and Biopolymers, “Petru Poni” Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, RomaniaCenter of Advanced Research in Bionanoconjugates and Biopolymers, “Petru Poni” Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, RomaniaCenter of Advanced Research in Bionanoconjugates and Biopolymers, “Petru Poni” Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, RomaniaDepartment of Pathophysiology and Pharmacology, Institute of Cellular Biology and Pathology “Nicolae Simionescu” of the Romanian Academy, 8 B.P. Hasdeu Street, 050568 Bucharest, RomaniaGlioblastoma (GB) is the most aggressive form of brain cancer in adults, characterized by poor survival rates and lack of effective therapies. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression post-transcriptionally through specific pairing with target messenger RNAs (mRNAs). Extracellular vesicles (EVs), a heterogeneous group of cell-derived vesicles, transport miRNAs, mRNAs and intracellular proteins, and have been shown to promote horizontal malignancy into adjacent tissue, as well as resistance to conventional therapies. Furthermore, GB-derived EVs have distinct miRNA contents and are able to penetrate the blood–brain barrier. Numerous studies have attempted to identify EV-associated miRNA biomarkers in serum/plasma and cerebrospinal fluid, but their collective findings fail to identify reliable biomarkers that can be applied in clinical settings. However, EVs carrying specific miRNAs or miRNA inhibitors have great potential as therapeutic nanotools in GB, and several studies have investigated this possibility on in vitro and in vivo models. In this review, we discuss the role of EVs and their miRNA content in GB progression and resistance to therapy, with emphasis on their potential as diagnostic, prognostic and disease monitoring biomarkers and as nanocarriers for gene therapy.https://www.mdpi.com/1999-4923/13/7/988extracellular vesiclesglioblastomamicroRNAbiomarkersnanocarrierstherapy
spellingShingle Natalia Simionescu
Radu Zonda
Anca Roxana Petrovici
Adriana Georgescu
The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
Pharmaceutics
extracellular vesicles
glioblastoma
microRNA
biomarkers
nanocarriers
therapy
title The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
title_full The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
title_fullStr The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
title_full_unstemmed The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
title_short The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
title_sort multifaceted role of extracellular vesicles in glioblastoma microrna nanocarriers for disease progression and gene therapy
topic extracellular vesicles
glioblastoma
microRNA
biomarkers
nanocarriers
therapy
url https://www.mdpi.com/1999-4923/13/7/988
work_keys_str_mv AT nataliasimionescu themultifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy
AT raduzonda themultifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy
AT ancaroxanapetrovici themultifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy
AT adrianageorgescu themultifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy
AT nataliasimionescu multifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy
AT raduzonda multifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy
AT ancaroxanapetrovici multifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy
AT adrianageorgescu multifacetedroleofextracellularvesiclesinglioblastomamicrornananocarriersfordiseaseprogressionandgenetherapy